Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 • 7,717 citations
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 • 3,605 citations
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
1992 • 2,042 citations
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 • 1,460 citations
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
1994 • 1,249 citations
Vascular permeability factor (VPF, VEGF) in tumor biology
1993 • 839 citations
The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins.
1986 • 575 citations
Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
1993 • 574 citations
Detection of p53 Gene Mutations in Human Brain Tumors by Single-strand Conformation Polymorphism Analysis of Polymerase Chain Reaction Products
1991 • 556 citations
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
1996 • 423 citations
The role of vascular endothelial growth factor in pathological angiogenesis
1995 • 419 citations
Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
1995 • 409 citations
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.
1994 • 352 citations
Analysis of the p53 gene and its expression in human glioblastoma cells.
1994 • 329 citations
Thrombospondin-1 Expression in Bladder Cancer: Association With p53 Alterations, Tumor Angiogenesis, and Tumor Progression
1997 • 328 citations
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
1996 • 306 citations
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors
1995 • 271 citations
Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
1995 • 257 citations
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.
1996 • 221 citations
AIDS-associated kaposi's sarcoma cells in culture express vascular endothelial growth factor
1992 • 164 citations
Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis.
1995 • 162 citations
Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
1996 • 145 citations
The role of thrombospondin‐1 in tumor progression and angiogenesis
1996 • 124 citations
Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia.
1997 • 113 citations
Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
1996 • 103 citations
Localization of thrombospondin in hepatocellular carcinoma
1997 • 21 citations
Cited By (0)
No citing papers found in database